Form 10-Q · Quarterly report
CDW Corporation 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0001402057
- Accession no.
- 0001402057-26-000065
Summary
CDW Corporation reported second-quarter 2026 net sales of $6.57 billion, up 10.0% from a year earlier, and net income of $274.4 million, or $2.15 per diluted share. The company also realigned its customer-facing sales organization effective January 1, 2026 into Commercial, Government, and Education reportable segments.
Key points
- Second-quarter net sales increased 10.0% to $6.57 billion, with growth across all operating segments and in data storage and servers, notebooks/mobile devices, software, and netcomm products.
- Net income rose to $274.4 million, or $2.15 per diluted share, from $271.2 million, or $2.05 per diluted share, a year earlier.
- Gross profit margin declined 70 basis points to 20.1%, which CDW attributed to mix into and lower margin in certain hardware categories.
- Effective January 1, 2026, CDW realigned its customer-facing sales organization into Commercial, Government, and Education reportable segments, with Small Business customers folded into Commercial channels.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview CDW Corporation (“Parent”) is a leading multi-brand provider of information technology (“IT”) solutions to business, government, education, and healthcare customers in the United States (“US”), the United Kingdom (“UK”), and Canada. Our broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Effective January 1, 2026, we realigned our customer-facing sales organization to better meet the evolving needs of our customer end markets. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.